Skip to main content
      RT @Lupusreference: 🎉 To celebrate the start of #ACR21, I'm happy to share this slide about #autoantibodies in system

      Laurent ARNAUD Lupusreference

      3 years 1 month ago
      🎉 To celebrate the start of #ACR21, I'm happy to share this slide about #autoantibodies in systemic #autoimmune diseases such as #lupus, sjogren, systemic sclerosis, myosotis...and their main targets 🎯 As you may guess this took me a few hours to assemble... https://t.co/fNmgfOFbiD
      RT @synovialjoints: Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions

      Dr. Antoni Chan synovialjoints

      3 years 1 month ago
      Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions at injection site, bone marrow transplant may be curative @RheumNow #ACR21 Session6S410 L Wilson, DO Cordona https://t.co/eQ1KVDiKKV
      RT @ELittlejohnDO: Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheuma

      Emily Littlejohn ELittlejohnDO

      3 years 1 month ago
      Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheumatic Diseases. A wonderful resource in talking to our patients about vaccine necessity! @CleClinicMD https://t.co/EA5jVYweHm
      RT @ERheumat: #ACR21 #ACR2021 Clinical Pearls
      🚨 Thread Alert
      1/n
      💥AAV does not typically cause hard palate lesio

      EnvisionRheumat ERheumat

      3 years 1 month ago
      #ACR21 #ACR2021 Clinical Pearls 🚨 Thread Alert 1/n 💥AAV does not typically cause hard palate lesions➡️consider: Cocaine induced midline destructive lesion(HNE+)/Malignancy 💥Limited GPA can be ANCA negetive in 50% 💥 oral cavity examination is a must in Rheum https://t.co/RxkLiGdcJt
      RT @ERheumat: #ACR21 #ACR2021
      Sjogrens syndrome with pulmonary involvement guidelines
      🚨Thread Alert
      👉🏻Screen a

      EnvisionRheumat ERheumat

      3 years 1 month ago
      #ACR21 #ACR2021 Sjogrens syndrome with pulmonary involvement guidelines 🚨Thread Alert 👉🏻Screen all patients for pulm inv. irrespective of symtopms ➡️ prevlance of lung involvement can be upto 65% 👉🏻Complete PFT includes ➡️ Spirometry➕ DLCO➕ PuseOximetry https://t.co/prFgQESRyF
      RT @AshimaMakol: Targeting the HUGE dilemma!🎯

      #Psoriatic vs Erosive #OA

      PsA
      👉 Fluffy bone formation(enthesitis

      Ashima Makol MD AshimaMakol

      3 years 1 month ago
      Targeting the HUGE dilemma!🎯 #Psoriatic vs Erosive #OA PsA 👉 Fluffy bone formation(enthesitis of phalanges) 👉 Marginal erosions(vs central) 👉 Many jts in same digit(ray inv) 👉 Periarticular SOFT tissue swelling (dactylitis). 👉 NOT much hand OA #ACR21 RadiologyBootCamp https://t.co/OQLPoeRLny
      RT @BolekBerqui: Live from #ACR21:
      Learning about osteoarthritis from Dr. Marc Hochberg.

      "Don't use the term degenerati

      Jilaine Bolek Berquist BolekBerqui

      3 years 1 month ago
      Live from #ACR21: Learning about osteoarthritis from Dr. Marc Hochberg. "Don't use the term degenerative joint disease." -much more involved. I like this figure of the multiple different phenotypes. #ACRAmbassador https://t.co/UwU4vCmYXa
      RT @MithuRheum: #ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri &

      Mithu Maheswaranathan, MD MithuRheum

      3 years 1 month ago
      #ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin Audience Vote 🗳: What would you add to mycophenolate first? Belimumab 71%, Voclosporin 29% #ACRAmbassador @ACRheum Summary of Pros & Cons of Each⬇️ https://t.co/OtLxs8IYr9
      RT @ericdeinmd: #ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis.
      Labs:
      +ANA
      +Anti-histone
      +

      Eric Dein ericdeinmd

      3 years 1 month ago
      #ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis. Labs: +ANA +Anti-histone +p-ANCA, +MPO and +PR3 @Rheumnow https://t.co/YQvqj0vCHp https://t.co/LPyVYYzLtI
      RT @ericdeinmd: #ACR21 2022 ACR/EULAR GPA Criteria
      ▶️Classification, NOT diagnostic!
      ⭐️Clinical, lab, imaging, a

      Eric Dein ericdeinmd

      3 years 1 month ago
      #ACR21 2022 ACR/EULAR GPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical, lab, imaging, and biopsy criteria ⭐️+5 pts for cANCA or PR3, negative pts for pANCA or MPO, or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/vg8zaFt5dR
      RT @ericdeinmd: #ACR21 TM26. Familial chilblains lupus seen in genetic mutation in Three Prime Repair Exonuclease 1 (TRE

      Eric Dein ericdeinmd

      3 years 1 month ago
      #ACR21 TM26. Familial chilblains lupus seen in genetic mutation in Three Prime Repair Exonuclease 1 (TREX1). Suspected due to onset in infancy. @Rheumnow https://t.co/ZryOpeoJT8 https://t.co/LqZqoGDAL2
      RT @Doctorkuch: #ACR21 Late breaking
      #ACRambassador
      Breakthrough COVID-19 Infections Post-vaccination Among Immunocompr

      Marie Kuchynski MD Doctorkuch

      3 years 1 month ago
      #ACR21 Late breaking #ACRambassador Breakthrough COVID-19 Infections Post-vaccination Among Immunocompromised Patients with Autoimmune or Inflammatory Rheumatic Diseases: A Retrospective Cohort Analysis from a U.S. Nationally-sampled EMR Data Repository https://t.co/oyovR27Upm
      RT @rheumarhyme: #ACR21 [Dr Pooni] #Telemedicine #Pediatrics providers felt PE was worsened BUT msk exam was the MOST re

      LiSa ◡̈︎ rheumarhyme

      3 years 1 month ago
      #ACR21 [Dr Pooni] #Telemedicine #Pediatrics providers felt PE was worsened BUT msk exam was the MOST reliable. @endocrine_witch @millennialpedia https://t.co/3FGCyBIxB2 https://t.co/fgwdk0WXKm
      RT @AshimaMakol: 👌Superb review of #SSc ILD by @sclerodermaUM #ACR21

      👉EARLY/SUBCLINICAL is NOT Mild ILD
      👉MMF 1

      Ashima Makol MD AshimaMakol

      3 years 1 month ago
      👌Superb review of #SSc ILD by @sclerodermaUM #ACR21 👉EARLY/SUBCLINICAL is NOT Mild ILD 👉MMF 1st 👉TCZ in combination for progressive phenotype/progression 👉Nintedanib:start slow, uptitrate for GI tolerability 👉Early HSCT referral (early dcSSc, FVC&DLCO 45-80%, Normal🫀) https://t.co/MUOhc3PakH
      RT @EBRheum: ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior

      Similar disclaimer; these are f

      Mike Putman EBRheum

      3 years 1 month ago
      ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior Similar disclaimer; these are for use AFTER the diagnosis of small or medium vasculitis has been made Great international effort, kudos to all involved #ACR21 #ACRambassador https://t.co/a29TVvzVF7
      ×